• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs have been updated today, June 1, 2021:
Effective July 1, 2021:

  • GLP-1
  • Androgens and Anabolic Steroids
  • Insulin
  • Methotrexate Injectable
  • Multiple Sclerosis
  • Opioid ER
  • Opioid IR Duration Limit
  • Self-Administered Oncology
  • VMAT2 Inhibitors
  • CGRP
  • Biologic Immunomodulators
  • Lupus (Previously Benlysta)
  • Sucraid
  • Xhance
  • Zeposia
  • Zokinvy

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.
Institutional Providers
Professional Providers